Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 102 | 2024 | 11097 | 4.590 |
Why?
|
Prostate-Specific Antigen | 14 | 2024 | 2463 | 1.360 |
Why?
|
Polymorphism, Single Nucleotide | 51 | 2024 | 16036 | 1.320 |
Why?
|
Kallikreins | 3 | 2024 | 219 | 1.180 |
Why?
|
Genome-Wide Association Study | 22 | 2023 | 12790 | 1.060 |
Why?
|
Urinary Bladder, Overactive | 2 | 2024 | 117 | 0.970 |
Why?
|
Genetic Predisposition to Disease | 35 | 2025 | 18063 | 0.950 |
Why?
|
Prostate | 11 | 2023 | 1761 | 0.940 |
Why?
|
Selenium | 4 | 2016 | 418 | 0.820 |
Why?
|
Urinary Incontinence, Stress | 1 | 2024 | 180 | 0.780 |
Why?
|
Pregnancy-Associated Plasma Protein-A | 1 | 2021 | 60 | 0.760 |
Why?
|
Serine Endopeptidases | 5 | 2023 | 1027 | 0.700 |
Why?
|
Insulin-Like Growth Factor I | 4 | 2023 | 1939 | 0.640 |
Why?
|
Chromosomes, Human, Pair 8 | 6 | 2024 | 451 | 0.620 |
Why?
|
Fecal Incontinence | 1 | 2019 | 246 | 0.550 |
Why?
|
Metformin | 2 | 2014 | 908 | 0.510 |
Why?
|
Germ-Line Mutation | 6 | 2025 | 1885 | 0.500 |
Why?
|
Urinary Incontinence | 1 | 2019 | 490 | 0.490 |
Why?
|
PTEN Phosphohydrolase | 5 | 2021 | 1119 | 0.480 |
Why?
|
Metabolomics | 3 | 2021 | 1675 | 0.460 |
Why?
|
Follow-Up Studies | 25 | 2024 | 39317 | 0.460 |
Why?
|
Genotype | 25 | 2024 | 13035 | 0.460 |
Why?
|
Selenoprotein P | 1 | 2012 | 33 | 0.420 |
Why?
|
Male | 107 | 2024 | 364203 | 0.410 |
Why?
|
Genetic Variation | 12 | 2016 | 6611 | 0.390 |
Why?
|
Case-Control Studies | 32 | 2025 | 22254 | 0.390 |
Why?
|
Gene Expression Profiling | 8 | 2023 | 9532 | 0.370 |
Why?
|
Oncogene Proteins, Fusion | 7 | 2024 | 1608 | 0.370 |
Why?
|
Colonic Neoplasms | 2 | 2020 | 2535 | 0.370 |
Why?
|
Genetic Markers | 5 | 2022 | 2602 | 0.360 |
Why?
|
Aged | 65 | 2025 | 171319 | 0.340 |
Why?
|
Selenoproteins | 2 | 2016 | 216 | 0.330 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2019 | 2902 | 0.320 |
Why?
|
Prostatectomy | 8 | 2020 | 1786 | 0.310 |
Why?
|
Repressor Proteins | 1 | 2019 | 2979 | 0.310 |
Why?
|
Humans | 119 | 2025 | 767040 | 0.310 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2009 | 418 | 0.290 |
Why?
|
Neoplasm Staging | 10 | 2021 | 11217 | 0.280 |
Why?
|
Risk Factors | 36 | 2025 | 74886 | 0.270 |
Why?
|
Nerve Tissue Proteins | 1 | 2019 | 4401 | 0.270 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 3 | 2023 | 416 | 0.270 |
Why?
|
Tissue Array Analysis | 4 | 2021 | 545 | 0.260 |
Why?
|
Middle Aged | 56 | 2025 | 223233 | 0.250 |
Why?
|
Prospective Studies | 27 | 2024 | 54886 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2024 | 8628 | 0.240 |
Why?
|
Endometrial Neoplasms | 2 | 2025 | 1381 | 0.240 |
Why?
|
Twins, Dizygotic | 2 | 2016 | 236 | 0.230 |
Why?
|
Disease Progression | 11 | 2024 | 13646 | 0.220 |
Why?
|
Genetic Loci | 4 | 2021 | 2629 | 0.220 |
Why?
|
Prognosis | 13 | 2024 | 29963 | 0.220 |
Why?
|
Proportional Hazards Models | 10 | 2024 | 12536 | 0.220 |
Why?
|
Urinary Incontinence, Urge | 1 | 2024 | 50 | 0.220 |
Why?
|
RNA, Messenger | 4 | 2017 | 12793 | 0.220 |
Why?
|
Organic Anion Transporters | 1 | 2024 | 101 | 0.210 |
Why?
|
Twins, Monozygotic | 2 | 2016 | 471 | 0.210 |
Why?
|
Receptors, Calcium-Sensing | 2 | 2015 | 320 | 0.200 |
Why?
|
Cohort Studies | 19 | 2024 | 41718 | 0.200 |
Why?
|
Choline | 1 | 2024 | 511 | 0.190 |
Why?
|
Superoxide Dismutase | 2 | 2015 | 596 | 0.190 |
Why?
|
DNA Repair-Deficiency Disorders | 1 | 2021 | 37 | 0.190 |
Why?
|
Vitamin D | 5 | 2024 | 3312 | 0.180 |
Why?
|
Hypoglycemic Agents | 1 | 2014 | 3108 | 0.180 |
Why?
|
Risk | 9 | 2021 | 9606 | 0.180 |
Why?
|
Aneuploidy | 1 | 2024 | 573 | 0.180 |
Why?
|
Body Mass Index | 6 | 2025 | 13048 | 0.180 |
Why?
|
Aged, 80 and over | 19 | 2022 | 59548 | 0.180 |
Why?
|
Odds Ratio | 8 | 2025 | 9660 | 0.170 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2022 | 553 | 0.170 |
Why?
|
Multifactorial Inheritance | 3 | 2023 | 1422 | 0.160 |
Why?
|
Confidence Intervals | 3 | 2021 | 2920 | 0.160 |
Why?
|
Serine Proteases | 1 | 2018 | 44 | 0.160 |
Why?
|
Linkage Disequilibrium | 8 | 2012 | 1996 | 0.150 |
Why?
|
Age Factors | 4 | 2025 | 18401 | 0.150 |
Why?
|
Breast Neoplasms | 10 | 2025 | 21178 | 0.150 |
Why?
|
Receptors, Calcitriol | 3 | 2024 | 361 | 0.150 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2024 | 3249 | 0.150 |
Why?
|
Quality of Life | 1 | 2019 | 13485 | 0.150 |
Why?
|
Body Height | 2 | 2021 | 1565 | 0.150 |
Why?
|
Urinary Bladder | 1 | 2024 | 1155 | 0.140 |
Why?
|
Drug Eruptions | 1 | 2020 | 335 | 0.140 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2025 | 934 | 0.140 |
Why?
|
Environment | 1 | 2023 | 1120 | 0.140 |
Why?
|
Genetic Association Studies | 4 | 2021 | 2744 | 0.140 |
Why?
|
Diabetes Mellitus | 2 | 2025 | 5886 | 0.140 |
Why?
|
DNA Modification Methylases | 1 | 2018 | 207 | 0.140 |
Why?
|
Transurethral Resection of Prostate | 1 | 2017 | 77 | 0.140 |
Why?
|
Extracellular Matrix Proteins | 1 | 2021 | 832 | 0.140 |
Why?
|
Squalene Monooxygenase | 1 | 2016 | 11 | 0.140 |
Why?
|
Inheritance Patterns | 1 | 2019 | 344 | 0.130 |
Why?
|
Glutathione Peroxidase | 2 | 2016 | 259 | 0.130 |
Why?
|
Neurosecretory Systems | 1 | 2017 | 223 | 0.130 |
Why?
|
Risk Assessment | 13 | 2024 | 24299 | 0.130 |
Why?
|
Chromosome Mapping | 5 | 2018 | 4616 | 0.130 |
Why?
|
DNA Repair Enzymes | 1 | 2018 | 342 | 0.130 |
Why?
|
Quantitative Trait Loci | 3 | 2019 | 2131 | 0.130 |
Why?
|
Haplotypes | 8 | 2018 | 2722 | 0.130 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2019 | 878 | 0.120 |
Why?
|
Neoplasm Invasiveness | 3 | 2021 | 3611 | 0.120 |
Why?
|
Molecular Epidemiology | 2 | 2014 | 473 | 0.120 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 3804 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2019 | 10393 | 0.120 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2021 | 1655 | 0.120 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 2 | 2023 | 126 | 0.120 |
Why?
|
Signal Transduction | 4 | 2024 | 23621 | 0.110 |
Why?
|
Genes, BRCA1 | 2 | 2010 | 753 | 0.110 |
Why?
|
Survival Analysis | 4 | 2015 | 10092 | 0.110 |
Why?
|
Electroretinography | 1 | 2016 | 524 | 0.110 |
Why?
|
Interleukin-4 | 1 | 2018 | 1156 | 0.110 |
Why?
|
Catalase | 1 | 2014 | 215 | 0.110 |
Why?
|
Adult | 23 | 2025 | 223317 | 0.110 |
Why?
|
Genes, myc | 2 | 2017 | 391 | 0.110 |
Why?
|
Models, Statistical | 2 | 2021 | 5098 | 0.110 |
Why?
|
Translocation, Genetic | 1 | 2018 | 1391 | 0.100 |
Why?
|
Cell Cycle Proteins | 1 | 2024 | 3440 | 0.100 |
Why?
|
Epigenomics | 1 | 2018 | 959 | 0.100 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2018 | 783 | 0.100 |
Why?
|
DNA Repair | 1 | 2021 | 2050 | 0.100 |
Why?
|
Sweden | 3 | 2024 | 1382 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2017 | 998 | 0.100 |
Why?
|
Stromal Cells | 1 | 2017 | 1335 | 0.100 |
Why?
|
Vitamin E | 1 | 2016 | 872 | 0.100 |
Why?
|
Receptors, Adiponectin | 1 | 2011 | 82 | 0.090 |
Why?
|
Metabolome | 1 | 2018 | 1008 | 0.090 |
Why?
|
Mendelian Randomization Analysis | 3 | 2023 | 1040 | 0.090 |
Why?
|
Early Detection of Cancer | 3 | 2023 | 3236 | 0.090 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6844 | 0.090 |
Why?
|
Promoter Regions, Genetic | 2 | 2021 | 5796 | 0.090 |
Why?
|
Prostatic Secretory Proteins | 1 | 2010 | 24 | 0.090 |
Why?
|
Receptor, IGF Type 1 | 1 | 2013 | 384 | 0.090 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2020 | 2883 | 0.090 |
Why?
|
Cholesterol | 2 | 2018 | 2905 | 0.090 |
Why?
|
Energy Intake | 1 | 2018 | 2145 | 0.090 |
Why?
|
Neoplasms | 2 | 2016 | 22350 | 0.090 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2010 | 62 | 0.090 |
Why?
|
Genetics, Population | 2 | 2006 | 943 | 0.090 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2010 | 275 | 0.080 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3944 | 0.080 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2201 | 0.080 |
Why?
|
Logistic Models | 3 | 2021 | 13284 | 0.080 |
Why?
|
Gene Fusion | 1 | 2012 | 356 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2017 | 3797 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2457 | 0.080 |
Why?
|
Adenocarcinoma | 2 | 2018 | 6360 | 0.080 |
Why?
|
ROC Curve | 1 | 2016 | 3618 | 0.080 |
Why?
|
Endoribonucleases | 1 | 2010 | 231 | 0.080 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 505 | 0.080 |
Why?
|
Double-Blind Method | 2 | 2013 | 12451 | 0.070 |
Why?
|
Paraffin Embedding | 2 | 2020 | 303 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 2018 | 2800 | 0.070 |
Why?
|
Toll-Like Receptor 4 | 1 | 2011 | 588 | 0.070 |
Why?
|
Epithelial Cells | 2 | 2017 | 3698 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2018 | 2906 | 0.070 |
Why?
|
DNA-Binding Proteins | 1 | 2024 | 9612 | 0.070 |
Why?
|
Molecular Sequence Annotation | 2 | 2021 | 526 | 0.070 |
Why?
|
Sequence Tagged Sites | 1 | 2006 | 96 | 0.070 |
Why?
|
Alleles | 5 | 2024 | 6893 | 0.070 |
Why?
|
Mutation, Missense | 4 | 2010 | 2592 | 0.070 |
Why?
|
Incidence | 6 | 2024 | 21526 | 0.070 |
Why?
|
Gene Dosage | 1 | 2010 | 1211 | 0.070 |
Why?
|
Immunohistochemistry | 4 | 2014 | 11063 | 0.060 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2007 | 304 | 0.060 |
Why?
|
Antioxidants | 1 | 2014 | 1671 | 0.060 |
Why?
|
DNA | 1 | 2019 | 7210 | 0.060 |
Why?
|
Adiponectin | 1 | 2011 | 1115 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2017 | 7611 | 0.060 |
Why?
|
Obesity | 3 | 2018 | 13085 | 0.060 |
Why?
|
Survival Rate | 3 | 2020 | 12823 | 0.060 |
Why?
|
C-Reactive Protein | 2 | 2014 | 3851 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2019 | 2930 | 0.060 |
Why?
|
Hypertension | 1 | 2024 | 8615 | 0.060 |
Why?
|
Female | 17 | 2025 | 396660 | 0.060 |
Why?
|
Androgen Antagonists | 2 | 2024 | 1412 | 0.060 |
Why?
|
United States | 8 | 2025 | 72971 | 0.060 |
Why?
|
Precancerous Conditions | 1 | 2010 | 980 | 0.050 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2007 | 637 | 0.050 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2024 | 350 | 0.050 |
Why?
|
BRCA1 Protein | 1 | 2010 | 1155 | 0.050 |
Why?
|
Europe | 2 | 2024 | 3432 | 0.050 |
Why?
|
Trans-Activators | 1 | 2012 | 2856 | 0.050 |
Why?
|
Receptor, Muscarinic M3 | 1 | 2022 | 37 | 0.050 |
Why?
|
Marital Status | 1 | 2024 | 426 | 0.050 |
Why?
|
Time Factors | 3 | 2019 | 40154 | 0.050 |
Why?
|
Calcium | 1 | 2015 | 5792 | 0.050 |
Why?
|
Contraceptives, Oral | 1 | 2025 | 560 | 0.050 |
Why?
|
Receptors, Purinergic | 1 | 2022 | 66 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11872 | 0.050 |
Why?
|
Gene Expression | 1 | 2014 | 7587 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4903 | 0.050 |
Why?
|
Biopsy | 2 | 2024 | 6777 | 0.050 |
Why?
|
Menarche | 1 | 2025 | 538 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2023 | 313 | 0.050 |
Why?
|
Cholinergic Antagonists | 1 | 2022 | 166 | 0.050 |
Why?
|
Life Style | 2 | 2024 | 3931 | 0.050 |
Why?
|
Parity | 1 | 2025 | 931 | 0.050 |
Why?
|
Receptors, Cholinergic | 1 | 2022 | 243 | 0.050 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2023 | 271 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2016 | 20169 | 0.050 |
Why?
|
Genes, BRCA2 | 1 | 2004 | 591 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 4925 | 0.050 |
Why?
|
TRPV Cation Channels | 1 | 2022 | 244 | 0.040 |
Why?
|
Stathmin | 1 | 2020 | 70 | 0.040 |
Why?
|
Bone Neoplasms | 1 | 2012 | 2563 | 0.040 |
Why?
|
Fanconi Anemia | 1 | 2021 | 327 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6966 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 431 | 0.040 |
Why?
|
Receptors, Androgen | 1 | 2004 | 1089 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15424 | 0.040 |
Why?
|
Medical History Taking | 1 | 2022 | 779 | 0.040 |
Why?
|
Registries | 3 | 2024 | 8351 | 0.040 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2025 | 1097 | 0.040 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2018 | 313 | 0.040 |
Why?
|
Diet, Mediterranean | 1 | 2024 | 746 | 0.030 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2018 | 432 | 0.030 |
Why?
|
Hawaii | 2 | 2006 | 101 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2022 | 81659 | 0.030 |
Why?
|
Androgens | 1 | 2024 | 1281 | 0.030 |
Why?
|
Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.030 |
Why?
|
Thioredoxin Reductase 1 | 1 | 2016 | 32 | 0.030 |
Why?
|
Selenium-Binding Proteins | 1 | 2016 | 18 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2021 | 12069 | 0.030 |
Why?
|
Seasons | 2 | 2012 | 1523 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2020 | 2472 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2017 | 245 | 0.030 |
Why?
|
Fluorouracil | 1 | 2020 | 1652 | 0.030 |
Why?
|
Smoking | 2 | 2025 | 9081 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2010 | 5332 | 0.030 |
Why?
|
Phospholipids | 1 | 2018 | 778 | 0.030 |
Why?
|
Germ Cells | 1 | 2018 | 644 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2024 | 17097 | 0.030 |
Why?
|
Norway | 1 | 2016 | 500 | 0.030 |
Why?
|
DNA Damage | 1 | 2024 | 2469 | 0.030 |
Why?
|
Finland | 1 | 2016 | 608 | 0.030 |
Why?
|
Social Class | 1 | 2023 | 2007 | 0.030 |
Why?
|
Trypsin Inhibitor, Kazal Pancreatic | 1 | 2014 | 30 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2019 | 13491 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2015 | 266 | 0.030 |
Why?
|
Social Support | 1 | 2024 | 2192 | 0.030 |
Why?
|
Microsatellite Repeats | 2 | 2007 | 784 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2017 | 4892 | 0.030 |
Why?
|
Phenotype | 3 | 2019 | 16718 | 0.030 |
Why?
|
Cell Differentiation | 1 | 2011 | 11657 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2023 | 2116 | 0.030 |
Why?
|
Denmark | 1 | 2016 | 776 | 0.030 |
Why?
|
Watchful Waiting | 1 | 2017 | 492 | 0.030 |
Why?
|
Epithelium | 1 | 2017 | 1606 | 0.030 |
Why?
|
Mice | 4 | 2024 | 81912 | 0.030 |
Why?
|
Retinoid X Receptor alpha | 1 | 2012 | 22 | 0.030 |
Why?
|
25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2012 | 57 | 0.030 |
Why?
|
Steroid Hydroxylases | 1 | 2012 | 93 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1791 | 0.020 |
Why?
|
Biological Transport | 1 | 2016 | 2084 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2015 | 9410 | 0.020 |
Why?
|
Vitamin D-Binding Protein | 1 | 2012 | 130 | 0.020 |
Why?
|
Testosterone | 1 | 2022 | 2490 | 0.020 |
Why?
|
Triglycerides | 1 | 2018 | 2444 | 0.020 |
Why?
|
Australia | 1 | 2014 | 1263 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2018 | 2353 | 0.020 |
Why?
|
Waist Circumference | 1 | 2013 | 935 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2024 | 5794 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7848 | 0.020 |
Why?
|
Self Report | 1 | 2021 | 3773 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2538 | 0.020 |
Why?
|
Algorithms | 2 | 2020 | 14098 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2010 | 630 | 0.020 |
Why?
|
Animals | 4 | 2024 | 168965 | 0.020 |
Why?
|
Mass Screening | 1 | 2023 | 5456 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2012 | 1141 | 0.020 |
Why?
|
Body Weight | 1 | 2017 | 4627 | 0.020 |
Why?
|
Bone and Bones | 1 | 2017 | 2587 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2019 | 3599 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2009 | 748 | 0.020 |
Why?
|
Human Genome Project | 1 | 2006 | 202 | 0.020 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2006 | 310 | 0.020 |
Why?
|
Los Angeles | 1 | 2006 | 245 | 0.020 |
Why?
|
Reference Values | 1 | 2012 | 4918 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 2827 | 0.010 |
Why?
|
Up-Regulation | 1 | 2013 | 4143 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2010 | 3093 | 0.010 |
Why?
|
Introns | 1 | 2006 | 965 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2009 | 1741 | 0.010 |
Why?
|
Loss of Heterozygosity | 1 | 2006 | 663 | 0.010 |
Why?
|
Vitamins | 1 | 2012 | 1639 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10869 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14476 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2015 | 65295 | 0.010 |
Why?
|
Gene Frequency | 1 | 2009 | 3621 | 0.010 |
Why?
|
California | 1 | 2006 | 1439 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 8048 | 0.010 |
Why?
|
Exons | 1 | 2006 | 2391 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2010 | 3227 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6067 | 0.010 |
Why?
|
Genomics | 1 | 2015 | 5924 | 0.010 |
Why?
|
Mental Disorders | 1 | 2019 | 6873 | 0.010 |
Why?
|
Young Adult | 1 | 2025 | 59980 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36582 | 0.010 |
Why?
|
Population Surveillance | 1 | 2006 | 2594 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2010 | 10455 | 0.010 |
Why?
|
Base Sequence | 1 | 2004 | 12414 | 0.010 |
Why?
|
Genome, Human | 1 | 2006 | 4441 | 0.010 |
Why?
|
MicroRNAs | 1 | 2009 | 3792 | 0.010 |
Why?
|
Computer Simulation | 1 | 2006 | 6260 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15925 | 0.010 |
Why?
|
Mutation | 1 | 2010 | 30211 | 0.000 |
Why?
|